
Opinion|Videos|June 21, 2024
Patient Satisfaction: Opportunity for Better Multiple Sclerosis Therapies
Experts in multiple sclerosis discuss overall patient satisfaction with current disease-modifying therapies for multiple sclerosis, highlighting the need for more therapies that stave off decline and disease progression.
Advertisement
Episodes in this series

- How is patient satisfaction overall with current disease modifying therapies for MS?
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
CAR T-Cell Therapies, Bispecific Antibodies Usher in New Era in R/R MCL
2
Barriers to Treatment in Pediatric Myasthenia Gravis: Jonathan Strober, MD
3
Global CKD Burden Nearly Doubles Since 1990, Reaching 788 Million Adults Worldwide
4
Ibrutinib-Based Frontline Regimens Narrow the Survival Gap in CLL
5















































